In-depth analysis: This key article from #PharmaDeals highlights a 31% decline in licensing deal flow in H1 2023. Read the full analysis in this article “#Licensing Down in H1 2023 as Dealmakers Remain Cautious”, to gain insights into the shifting landscape. #BIOEurope https://bit.ly/3Qgk7ZY
IQVIA Global Market Insights’ Post
More Relevant Posts
-
Collaborative alliances in H1 2024 fell by 8% from H1 2023, remaining below pre-pandemic times. Find out more about the key trends and standout deals shaping the #PharmaceuticalIndustry in the #PharmaDeals H1 Review of 2024 https://bit.ly/3zSjSQI #StrategicPartnerships #BioEurope
To view or add a comment, sign in
-
Last day at #CPHIMilan2024! This is your last chance to meet our team face-to-face and discover how we can help boost efficiency and innovation in your business! Two essential demos you can't afford to miss today at the IQVIA booth 2C73, Hall 2: 11:00 IQVIA MIDAS™: CDMOs and innovative drug development 15:00 eQMS SmartSolve: Mastering quality process management You can also book your personalized demo here: https://bit.ly/3zOOwdL #IQVIAMIDAS #drugdevelopment
To view or add a comment, sign in
-
**Are you prepared for changes in patient populations in the next decade?** Find out at IQVIA's booth 2C73, Hall 2 at #CPHIMilan2024 to align your pipeline with future demand. See how IQVIA Analytics Link Ecosystem can forecast treatment trends and patient needs. Our experts will show you how to identify high-growth areas and potential market gaps. Qualified visitors may receive a complimentary 1-week trial. #PatientPopulations #TreatmentTrends #MarketInsights #AnalyticsLink #FreeTrialOffer
To view or add a comment, sign in
-
Live at #CPHIMilan2024! Aurelio Arias unveils the future of oncology, powered by MIDAS Disease and IQVIA Trial Link data. These insights are shaping the next advancements in patient outcomes, drug launches, clinical trials, manufacturing, and off-patent strategies. If you want to learn how it impacts your business, visit our booth 2C73, Hall 2 and talk to a member of our team. https://bit.ly/4gZQzfO
To view or add a comment, sign in
-
Here’s IQVIA’s Aurelio Arias presenting yesterday at #CPHIMilan2024. Catch him today at 4:40 PM in Hall 3 - 3F97 for the “Exploring Emerging Innovations in Oncology” presentation. Discover the future of patient outcomes, drug launches, clinical trials, manufacturing, and off-patent opportunities in oncology. See you there! https://bit.ly/3ZXbcTD
To view or add a comment, sign in
-
It was a busy first day at #CPHIMilan2024 for our IQVIA Global Market Insights team. We were delighted to connect with so many familiar faces and meet new colleagues from across the healthcare industry. Later in the evening, our team found that collaborative thinking pairs well with a good meal! It’s great to have our global team together for this event. Today, join us for our demos. Whether you’re a long-time partner or new to IQVIA, we’re eager to discuss how our insights can support your goals. Today’s demo schedule on booth 2C73, Hall 2: 12:00 - IQVIA Chemical Intelligence: Connecting global purchasers, sellers, and researchers in the chemical industry 15:00 - eQMS SmartSolve: Mastering quality process management Or you can book your personalized demo here: https://bit.ly/402kpdD
To view or add a comment, sign in
-
OUT NOW: The 2024 edition of #ChannelDynamics Global Reference has just been released! Gain valuable insights on sales force and marketing channel engagement in the #lifesciences industry. Discover trends and performance metrics for channel mix, share of voice and spend, therapy areas, sales force size rep equivalents, HCP channel preference, oncology, and more. Download the overview now: https://bit.ly/3YgTpWs
To view or add a comment, sign in
-
Which molecules in your therapeutic area will face patent expiry by 2028? Find out at our booth 2C73, Hall 2 at #CPHIMilan2024 to uncover potential threats and opportunities. Our IQVIA Analytics Link Ecosystem offers unparalleled insights into market evolution and product lifecycles. Get your data-driven forecasts to guide your long-term planning. Eligible visitors can explore a free 1-week trial. #PatentExpiry #MarketDynamics #ProductStrategy #AnalyticsLink #FreeTrialOffer
To view or add a comment, sign in
-
TODAY: Head to Hall 3 – 3F97 to secure your seat! Discover the latest insights on cost savings and expanded treatment options for biosimilars. Don’t miss it!
Double the biosimilar insights at #CPHIMilan2024! Join IQVIA's Aurelio Arias on Oct 8 for two back-to-back sessions. Discover real-world examples of #biosimilar challenges and explore their role in expanding critical treatment access. Aurelio will share expert insights on cost-saving potential and adoption strategies. Don’t miss these thought-provoking sessions! And if you want to talk help with your challenges, find us on stand 2C73. Learn more https://bit.ly/4817meo 3:45 PM: "Optimizing Biosimilar Use for Sustainable Healthcare" 4:15 PM: Fireside Chat on "Improving Patient Access with Biosimilars"
To view or add a comment, sign in
19,954 followers